DeutschNewstral
Article
jdsupra.com on 2019-08-06 16:54
Amgen Files New Patent Infringement Suit Over Neupogen Biosimilar
Related news
- Amgen Sues Pfizer and Hospira for Patent Infringement related to Hospira’s Filgrastim Biosimilarjdsupra.com
- Following Biosimilar Trial, Jury Awards Amgen $70 Million for Pfizer’s Pre-Approval Infringement of Now-Expired EPO Patentjdsupra.com
- Amgen Wins Injunction against Neupogen® Biosimilar Pending Appealjdsupra.com
- Amgen Files Cross-Appeal In Epoetin Alfa Biosimilar Casejdsupra.com
- Jury Awards Bayer $155 Million in Hemophilia Patent Infringement Suitjdsupra.com
- IoT Lighting Industry Giants Hit with Patent Infringement Suitjdsupra.com
- Amneal Seeks Dismissal as Defendant in Amgen v. Adello Filgrastim Biosimilar Suitjdsupra.com
- Patent Infringement Suit Against Product Manufacturer Partially Doomed by Prior Suit Against Component Supplierjdsupra.com
BlackBerry files patent infringement suit against Facebook, Instagram, WhatsAppCBC
Bug-A-Salt Files Patent Infringement Suit Against Dillard’s Inc.artesianews.com- Amgen Sues Pfizer Over Proposed Neulasta Biosimilarjdsupra.com
- Genentech Files Patent Infringement Complaint Against Lilly Regarding Lilly’s Taltz® Productjdsupra.com
- District of Colorado Upholds Eligibility of Liquid Cannabinoid Formulations in First-Ever Cannabis Patent Infringement Suitjdsupra.com
- Judge Connolly Issues Claim Construction Opinion For Remaining Disputed Claim Term In Patent-In-suit In Patent Infringement Actionjdsupra.com
- New BPCIA Complaint: Amgen Sues Pfizer over Proposed Filgrastim Biosimilarjdsupra.com
- New BPCIA Complaint: Genentech Sues Amgen over Proposed Trastuzumab Biosimilarjdsupra.com
- Another Biosimilar Litigation Settlement: Amgen v. Tanvex (Filgrastim)jdsupra.com
- Biosimilar-Related Patent Litigation Updatesjdsupra.com
- Amgen and Apotex do the Biosimilar Patent Dancejdsupra.com
- Scheduling Order Entered in Amgen v. Adello Filgrastim Biosimilar Litigationjdsupra.com